NCT03599700 is a clinical trial of myeloproliferative neoplasms in Thrombosis, sponsored by Assiut University.

Who is sponsoring NCT03599700?

NCT03599700 is sponsored by Assiut University.

What drugs are being tested in NCT03599700?

Interventions in NCT03599700: myeloproliferative neoplasms.

What condition does NCT03599700 study?

NCT03599700 studies Thrombosis.

Is NCT03599700 still recruiting?

NCT03599700 is currently status unknown. Last updated 21 February 2021.

Last reviewed 2021-02-21 · How we verify

NCT03599700

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk Factors and Predictors of Thrombosis in Myeloprolferative Neoplasms

Status unknown Last updated 21 February 2021

What this trial tests

trial testing myeloproliferative neoplasms in Thrombosis in 165 participants. Status unknown.

Timeline

20 December 2019

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	165
Start date	20 December 2019
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	1 location across Egypt

Drugs / interventions tested

myeloproliferative neoplasms

Conditions studied

Thrombosis — all drugs for Thrombosis →

Sponsor

Assiut University

Who can join

18 and older, any sex, with Thrombosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the clinical risk factors and predictable biomarkers of thrombotic complications in cases of philadelphia negative myeloproliferative disorders.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Thrombosis

Currently open trials in the same condition.

NCT07137429 — Platelet Volunteers, Longitudinal and Multi-omic Study · recruiting
NCT06676904 — Neonatal Platelet Transfusion Threshold Trial · NA · recruiting
NCT06993740 — Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient · NA · recruiting
NCT07358416 — Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery. · active not recruiting
NCT06370273 — Thromboprophylaxis in Lower Limb Immobilisation · Phase 3 · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03599700 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 21 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03599700.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing